Tumor hyaluronan as a novel biomarker in non-small cell lung cancer: A retrospective study.

Oncotarget(2022)

引用 0|浏览20
暂无评分
摘要
In this NSCLC cohort, tumor HA level represents a potential biomarker for TTP, which remains a cornerstone of NSCLC therapy. Further validation is warranted to identify the HA accumulation threshold associated with clinical benefit.
更多
查看译文
关键词
biomarker,hyaluronan,hyaluronic acid,predictive,prognostic
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要